{
    "2021-10-11": [
        [
            {
                "time": "2021-10-11",
                "original_text": "复星医药：本集团实际对外担保金额按2021年10月11日汇率折合人民币约约216.09亿元 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "大额借贷担保",
                        "对外担保"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-12",
                "original_text": "复星医药：控股子公司拟设立合资公司，并认缴51%资本",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "合资",
                        "认缴资本"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-13",
                "original_text": "复星医药：控股子公司通过GMP符合性检查",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "GMP符合性检查"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-14",
                "original_text": "复星医药：拟共同投资设立苏州星晨，于苏州市设立并运营营利性三级儿童医疗机构",
                "features": {
                    "keywords": [
                        "复星医药",
                        "苏州星晨",
                        "儿童医疗机构"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-15",
                "original_text": "复星北铃公共卫生应急产业与重症诊疗技术工程中心正式奠基开工",
                "features": {
                    "keywords": [
                        "复星北铃",
                        "公共卫生",
                        "应急产业",
                        "重症诊疗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "公共卫生"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}